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Q fever (Coxiella burnetii) causing an infected
thoracoabdominal aortic aneurysm
Bianca L. W. Bendermacher, MD, PhD,a Arnoud G. Peppelenbosch, MD, PhD,a
Jan Willem H. C. Daemen, MD, PhD,a Astrid M. L. Oude Lashof, MD,b and
Michael J. Jacobs, MD, PhD,a Maastricht, The Netherlands
We report a patient, which we believe is the first, with a thoracoabdominal aortic aneurysm, Crawford type IV, caused by
Q fever (Coxiella burnetii). Treatment consisted of antibiotic therapy started preoperatively and continued postopera-
tively and an open repair, including resection of the infected aneurysm, replacement with a rifampin-soaked polyester
graft, and an omental wrap covering the grafts. After 13 months of follow-up, the patient had no signs of infection, and
results of laboratory findings were normal. ( J Vasc Surg 2011;53:1402-4.)
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AAn infected aortic aneurysm is a rare disease with an
incidence of approximately 1%.1 The most commonly in-
volved organisms are Staphylococcus and Salmonella. How-
ever, approximately 25% of infected aneurysms remain
without bacterial identification.2 Reasons for this are vari-
ous, including administrating antibiotics before cultures are
taken, and infections with slow-growing or fastidious bac-
teria, or obligate intracellular bacteria, that are difficult to
culture. One of these pathogens is Coxiella burnetii.
In patients with underlying vascular disease, such as an
aortic aneurysm, C burnetii can cause chronic Q fever
infection.3,4 This is due to the affinity of C burnetii for
cardiovascular tissues and its ability to survive within the
phagolysosome after gaining entry into monocytes and
macrophages that are present in the aortic thrombus.5 To
date, 26 patients have been described in the literature with
C burnetii infection in combination with an aneurysm of
the native aorta,6-9 including two cases of a thoracoab-
dominal aortic aneurysm (TAAA) without confirmation of
C burnetii DNA. In this article, we report what we believe
is the first case of a patient with a TAAA caused by chronic
Q fever, confirmed by molecular detection of C burnetii
DNA in the aortic wall.
CASE REPORT
In September 2009, a 59-year-old man was admitted to a
regional hospital for analysis of radiating abdominal pain and high
fever (38.6° C). His relevant medical history revealed a coronary
artery bypass graft in 1992 and endovascular repair of an infrarenal
AAA in 2002.
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1402Laboratory tests showed an increased C-reactive protein of
0 mg/L (normal5 mg/L), elevated erythrocyte sedimentation
age of 41 mm/h (normal 20 mm/h), and leukocyte level of
.4  109/L (normal range, 4-10  109/L).
The initial computed tomography (CT) scan identified a sac-
ular aneurysm of the TAAA, Crawford type IV, with a maximum
iameter of 4.1 cm (Fig, A). Subsequent positron-emission to-
ography scanning showed an area of increased intensity of the
upraceliac aneurysm, without increased intensity of the infrarenal
ndoprosthesis, suggestive for a mycotic aortic aneurysm. Because
e lived in an area endemic for Q fever, serology for Q fever was
erformed and showed a chronic infection of C burnetii (immu-
ofluorescent assay phase 1 immunoglobulin G (IgG) 1: 4086;
hase 2 IgG1: 4086). Antibiotic therapy was started, consisting
f doxycycline (200 g/d and hydrochloroquine (200 mg orally,
wice daily), and he was referred to our hospital for further treat-
ent of the mycotic TAAA. Here, a repeat CT scan 1 month later
howed a growing infected TAAA with a diameter of 6.0 cm
Fig, B).
In November 2009, an open repair of the TAAA type IV was
erformed, with replacement of a rifampin-soaked polyester graft.
uring the procedure, distal aortic perfusion was performed using
ardiopulmonary bypass with a femoral artery canula and a femoral
ein canula up to the right atrium.Motor-evoked potential record-
ng was performed to evaluate spinal cord function during cross-
lamping.10
Rigorous debridement was done of the infected aneurysmatic
orta, and samples were sent for pathologic as well as microbiologic
xamination. The left renal artery was reconstructed with an 8-mm
raft, and the celiac trunk, superficial mesenteric artery, and right
enal artery were anastomosed at the distal end of the main graft.
n omental flap was harvested and wrapped around the thoracic
raft. Pathologic examination of the aortic wall showed activity of
nfection, and a quantitative real-time polymerase chain reaction
rt-PCR) amplification detected DNA of C burnetii in the aortic
all tissue.
His postoperative course was uneventful and the intrave-
ous antibiotic therapy with doxycycline (100 mg, twice daily)
nd rifampin (600 mg, twice daily) was continued for 5 weeks.
fter the definitive diagnosis, the antibiotics were switched to
ral doxycycline (100 mg, twice daily) and oral hydroxychloro-
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Volume 53, Number 5 Bendermacher et al 1403quine (200 mg, thrice daily) and will be continued for at least 18
months. After 13 months of follow-up, there were no com-
plaints, and the follow-up CT scan showed a stable condition of
the aorta.
DISCUSSION
This case report demonstrates the rare manifestation of
an infected TAAA caused by chronic Q fever. Because of
the presence of abdominal complaints, fever, increased
inflammatory parameters, and radiologic findings, together
with the fact that our patient lived in an area with a large Q
fever outbreak,11 an infection with C burnetii was sus-
pected at an early stage.
An English literature search revealed 26 cases of
chronic Q fever infection with a vascular manifestation of
the native aorta, whereas in 2 of these cases the TAA was
involved.6-9 In contrast with our patient, C burnetii could
not be isolated in the two TAAA patients9 by PCR from the
aneurysm. Their diagnosis was based on positive serology
Fig. Single-image from the preoperative computed tomography
(CT) scans of the mycotic thoracic thoracoabdominal aortic aneu-
rysm (TAAA). A, The first CT scan showed a TAAA of 4.1 cm in
diameter. B, The CT scan 2 months later showed a TAAA of 6.0
cm in diameter.only, associated with the TAAA. In our patient, however,e could demonstrate C burnetii DNA in the aneurysm,
onfirming the diagnosis of infected TAAA by Q fever. The
t-PCR used in our patient targets the insertion element
S1111 that is present in multiple copies in the C burnetii
enome, ensuring sensitive detection of the bacterium.
The aerosol inhalation is the primary mode of human
ontamination by C burnetii, which may occur directly
rom infected animals. The organismmay also spread by the
ind,12 and for this reason, Q fever may occur in patients
ho live in urban areas without any evident contact with
nimals. It is now well established that development of a
hronic infection is more often due to predisposing factors
n the host than the virulence of the bacterium.
Because infected aneurysms of the aorta are fatal if
ntreated,13 surgical and medical treatment are both nec-
ssary. En bloc resection of both the aneurysm and the
erianeurysmal infected tissue and in situ prosthetic graft
eplacement with reimplantation of visceral or renal arteries
re the basic principles of operation formycotic TAAA.14,15
n situ replaced prosthetic grafts should be soaked with
ifampin,16-18 whereas it has already been demonstrated to
ind significantly to gelatin-sealed Dacron grafts.2
Medical treatment consists of intensive antibiotic ther-
py, which is crucial for successful treatment and should be
tarted perioperatively. The required duration of antibiotic
herapy is not well established. Recommendations range
rom 6 to 8 weeks to lifelong antibiotic therapy.16,19 These
hould be stopped only when all infectious signs and blood
ultures are negative. The current recommendation for the
reatment of Q fever vascular infection is a combination of
oxycycline and hydroxychloroquine administered for a
inimum of 18 to 36 months.2,20 Regular controls with
T scans and control of infection parameters are necessary,
ecause recurrent or persistent aortic or graft infections
ight occur.16,21
ONCLUSION
For patients with a vascular medical history who live in
n endemic area for Q fever and complain of abdominal
ain with fever, an infected aneurysm due to Q fever should
e included in the differential diagnosis.
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